, 6.
Table of Contents
1. Chapter 01: Nursing Practice in Canada and Drug Therapy
2. Chapter 02: Pharmacological Principles
3. Chapter 03: Legal and Ethical Considerations
4. Chapter 04: Patient-Focused Considerations
5. Chapter 05: Gene Therapy and Pharmacogenomics
6. Chapter 06: Medication Errors: Preventing and Responding
7. Chapter 07: Patient Education and Drug Therapy
8. Chapter 08: Over-the-Counter Drugs and Natural Health Products
9. Chapter 09: Vitamins and Minerals
10. Chapter 10: Principles of Drug Administration
11. Chapter 11: Antiinfective Drugs
12. Chapter 12: Antiinfective Drugs, Part 2: Antitubercular, Antifungal, Antiviral, and Antimalarial Dru
13. Chapter 13: Antiinflammatory and Antigout Drugs
14. Chapter 14: Antineoplastic (Cancer) Drugs
15. Chapter 15: Analgesic Drugs
16. Chapter 16: Anesthetic Drugs
17. Chapter 17: Anticonvulsants and Antiparkinson Drugs
18. Chapter 18: Psychotherapeutic Drugs
19. Chapter 19: Adrenergic Drugs
20. Chapter 20: Adrenergic-Blocking Drugs
21. Chapter 21: Cholinergic Drugs
22. Chapter 22: Cholinergic-Blocking Drugs
23. Chapter 23: Antihypertensive Drugs
24. Chapter 24: Antianginal Drugs
25. Chapter 25: Heart Failure Drugs
26. Chapter 26: Antidysrhythmic Drugs
27. Chapter 27: Coagulation Modifier Drugs
28. Chapter 28: Antilipemic Drugs
29. Chapter 29: Diuretic Drugs
30. Chapter 30: Fluids and Electrolytes
31. Chapter 31: Nutritional Supplements and Herbal Products
32. Chapter 32: Antidiabetic Drugs
33. Chapter 33: Adrenal Drugs
34. Chapter 34: Thyroid and Antithyroid Drugs
35. Chapter 35: Pituitary Drugs
36. Chapter 36: Women’s Health Drugs
37. Chapter 37: Men’s Health Drugs
38. Chapter 38: Antihistamines, Decongestants, Antitussives, and Expectorants
39. Chapter 39: Respiratory Drugs
40. Chapter 40: Gastrointestinal Drugs
41. Chapter 41: Antiemetic and Antinausea Drugs
42. Chapter 42: Bowel Disorder Drugs
43. Chapter 43: Acid-Controlling Drugs
44. Chapter 44: Skin Drugs
45. Chapter 45: Eye and Ear Drugs
46. Chapter 46: Bone and Joint Drugs
47. Chapter 47: Immunizing Drugs
48. Chapter 48: Emergency and Critical Care Drugs
49. Chapter 49: Substance Abuse
,Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
Chapter 01: Nursing Practice in Canada and Drug Therapy Sealock: Lilley’s Pharmacology for
Practice, 4th Edition
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
CORRECT ANSWER:: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement is made about
heath conditions and life processes or vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the patient is unable to swal
medication orally, as ordered. The nurse needs to contact the physician. What type of problem is this? a.
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
CORRECT ANSWER:: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the route with the p
time” problem because the ordered frequency has not changed. This is not a “right dose” problem beca
an inability to swallow. This is not a “right medication” problem because the medication ordered will n
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen since the first dose and has
possible adverse effects. What nursing process phase is the nurse practising?
a. Planning
b. Evaluation
c. Implementation
d. Nursing diagnosis
CORRECT ANSWER:: B
Monitoring the patient’s progress is part of the evaluation phase. Planning, implementation, and nursing
by this example.
DIF: Cognitive Level: Application
4. The nurse is caring for a patient who has been newly diagnosed with type 1 diabetes mellitus. Which state
outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient adheres to the new insulin treatment regimen.
d. The patient demonstrates safe insulin self-administration technique.
CORRECT ANSWER:: D
, 6.
1. Which of the following best defines pharmacology?
a) The study of disease processes and their treatments
b) The study of how drugs interact with living systems
c) The study of how the body metabolizes food
d) The study of genetic predispositions to disease
Correct
Correct Answer:wer: b) The study of how drugs interact with living systems
Rationale: Pharmacology focuses on the study of drugs and their interactions with living systems, including mech
therapeutic uses, and side effects. Option (a) refers to pathology; (c) refers to nutrition; (d) refers to genetics.
2. Which statement best describes a "prototype drug"?
a) It is the safest drug in its class
b) It is the first drug discovered by a pharmaceutical company
c) It is the representative drug in a class used for comparison
d) It is the only FDA-approved drug in its class
Correct
Correct Answer:wer: c) It is the representative drug in a class used for comparison
Rationale: Prototype drugs represent the standard by which all other drugs in a class are compared. They help pred
effects. It does not necessarily mean it was the first discovered (b) or the safest (a).
3. Which factor primarily determines a drug’s effectiveness?
a) Its bioavailability
b) Its ability to elicit the desired response
c) Its low cost and convenience
d) Its minimal side effects
Correct
Correct Answer:wer: b) Its ability to elicit the desired response
Rationale: Drug effectiveness refers to the extent to which a drug produces its intended therapeutic effect. Althoug
cost (c), and minimal side effects (d) are important, they are not the primary determinant of effectiveness.
4. Which of the following is NOT considered a property of an ideal drug?
a) Reversible action
b) Predictability
c) Lack of drug interactions
d) Instability in storage
Correct
Correct Answer:wer: d) Instability in storage
Rationale: An ideal drug should have stable shelf life. Other properties include reversible action (ability to stop its
predictability of response, and minimal interactions. Instability is undesirable.
Table of Contents
1. Chapter 01: Nursing Practice in Canada and Drug Therapy
2. Chapter 02: Pharmacological Principles
3. Chapter 03: Legal and Ethical Considerations
4. Chapter 04: Patient-Focused Considerations
5. Chapter 05: Gene Therapy and Pharmacogenomics
6. Chapter 06: Medication Errors: Preventing and Responding
7. Chapter 07: Patient Education and Drug Therapy
8. Chapter 08: Over-the-Counter Drugs and Natural Health Products
9. Chapter 09: Vitamins and Minerals
10. Chapter 10: Principles of Drug Administration
11. Chapter 11: Antiinfective Drugs
12. Chapter 12: Antiinfective Drugs, Part 2: Antitubercular, Antifungal, Antiviral, and Antimalarial Dru
13. Chapter 13: Antiinflammatory and Antigout Drugs
14. Chapter 14: Antineoplastic (Cancer) Drugs
15. Chapter 15: Analgesic Drugs
16. Chapter 16: Anesthetic Drugs
17. Chapter 17: Anticonvulsants and Antiparkinson Drugs
18. Chapter 18: Psychotherapeutic Drugs
19. Chapter 19: Adrenergic Drugs
20. Chapter 20: Adrenergic-Blocking Drugs
21. Chapter 21: Cholinergic Drugs
22. Chapter 22: Cholinergic-Blocking Drugs
23. Chapter 23: Antihypertensive Drugs
24. Chapter 24: Antianginal Drugs
25. Chapter 25: Heart Failure Drugs
26. Chapter 26: Antidysrhythmic Drugs
27. Chapter 27: Coagulation Modifier Drugs
28. Chapter 28: Antilipemic Drugs
29. Chapter 29: Diuretic Drugs
30. Chapter 30: Fluids and Electrolytes
31. Chapter 31: Nutritional Supplements and Herbal Products
32. Chapter 32: Antidiabetic Drugs
33. Chapter 33: Adrenal Drugs
34. Chapter 34: Thyroid and Antithyroid Drugs
35. Chapter 35: Pituitary Drugs
36. Chapter 36: Women’s Health Drugs
37. Chapter 37: Men’s Health Drugs
38. Chapter 38: Antihistamines, Decongestants, Antitussives, and Expectorants
39. Chapter 39: Respiratory Drugs
40. Chapter 40: Gastrointestinal Drugs
41. Chapter 41: Antiemetic and Antinausea Drugs
42. Chapter 42: Bowel Disorder Drugs
43. Chapter 43: Acid-Controlling Drugs
44. Chapter 44: Skin Drugs
45. Chapter 45: Eye and Ear Drugs
46. Chapter 46: Bone and Joint Drugs
47. Chapter 47: Immunizing Drugs
48. Chapter 48: Emergency and Critical Care Drugs
49. Chapter 49: Substance Abuse
,Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
Chapter 01: Nursing Practice in Canada and Drug Therapy Sealock: Lilley’s Pharmacology for
Practice, 4th Edition
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
CORRECT ANSWER:: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement is made about
heath conditions and life processes or vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the patient is unable to swal
medication orally, as ordered. The nurse needs to contact the physician. What type of problem is this? a.
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
CORRECT ANSWER:: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the route with the p
time” problem because the ordered frequency has not changed. This is not a “right dose” problem beca
an inability to swallow. This is not a “right medication” problem because the medication ordered will n
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen since the first dose and has
possible adverse effects. What nursing process phase is the nurse practising?
a. Planning
b. Evaluation
c. Implementation
d. Nursing diagnosis
CORRECT ANSWER:: B
Monitoring the patient’s progress is part of the evaluation phase. Planning, implementation, and nursing
by this example.
DIF: Cognitive Level: Application
4. The nurse is caring for a patient who has been newly diagnosed with type 1 diabetes mellitus. Which state
outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient adheres to the new insulin treatment regimen.
d. The patient demonstrates safe insulin self-administration technique.
CORRECT ANSWER:: D
, 6.
1. Which of the following best defines pharmacology?
a) The study of disease processes and their treatments
b) The study of how drugs interact with living systems
c) The study of how the body metabolizes food
d) The study of genetic predispositions to disease
Correct
Correct Answer:wer: b) The study of how drugs interact with living systems
Rationale: Pharmacology focuses on the study of drugs and their interactions with living systems, including mech
therapeutic uses, and side effects. Option (a) refers to pathology; (c) refers to nutrition; (d) refers to genetics.
2. Which statement best describes a "prototype drug"?
a) It is the safest drug in its class
b) It is the first drug discovered by a pharmaceutical company
c) It is the representative drug in a class used for comparison
d) It is the only FDA-approved drug in its class
Correct
Correct Answer:wer: c) It is the representative drug in a class used for comparison
Rationale: Prototype drugs represent the standard by which all other drugs in a class are compared. They help pred
effects. It does not necessarily mean it was the first discovered (b) or the safest (a).
3. Which factor primarily determines a drug’s effectiveness?
a) Its bioavailability
b) Its ability to elicit the desired response
c) Its low cost and convenience
d) Its minimal side effects
Correct
Correct Answer:wer: b) Its ability to elicit the desired response
Rationale: Drug effectiveness refers to the extent to which a drug produces its intended therapeutic effect. Althoug
cost (c), and minimal side effects (d) are important, they are not the primary determinant of effectiveness.
4. Which of the following is NOT considered a property of an ideal drug?
a) Reversible action
b) Predictability
c) Lack of drug interactions
d) Instability in storage
Correct
Correct Answer:wer: d) Instability in storage
Rationale: An ideal drug should have stable shelf life. Other properties include reversible action (ability to stop its
predictability of response, and minimal interactions. Instability is undesirable.
